BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND FGFR4, CD334, 2264, ENSG00000160867, P22455, MGC20292, TKF, JTK2
18 results:

  • 1. Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
    Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
    Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clonal Hematopoiesis Risk Score and All-Cause and Cardiovascular Mortality in Older Adults.
    Saadatagah S; Uddin MM; Weeks LD; Niroula A; Ru M; Takahashi K; Gondek L; Yu B; Bick AG; Ebert BL; Platz EA; Natarajan P; Ballantyne CM
    JAMA Netw Open; 2024 Jan; 7(1):e2351927. PubMed ID: 38231513
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns.
    Clavé S; Rodon N; Pijuan L; Díaz O; Lorenzo M; Rocha P; Taus Á; Blanco R; Bosch-Barrera J; Reguart N; de la Torre N; Oliveras G; Espinet B; Bellosillo B; Puig X; Arriola E; Salido M
    Clin Lung Cancer; 2019 Jul; 20(4):e421-e429. PubMed ID: 30898567
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Germline variant fgfr4  p.G388R exposes a membrane-proximal STAT3 binding site.
    Ulaganathan VK; Sperl B; Rapp UR; Ullrich A
    Nature; 2015 Dec; 528(7583):570-4. PubMed ID: 26675719
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma.
    Cha Z; Zang Y; Guo H; Gu H; Tu X; Song H; Qian B
    Mol Biol Rep; 2014 Feb; 41(2):1165-70. PubMed ID: 24381107
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin's lymphoma.
    Gao L; Feng Z; Li Q; Li L; Chen L; Xiao T
    Tumour Biol; 2014 Apr; 35(4):2997-3002. PubMed ID: 24248544
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. FGF receptors: cancer biology and therapeutics.
    Katoh M; Nakagama H
    Med Res Rev; 2014 Mar; 34(2):280-300. PubMed ID: 23696246
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression.
    Ye YW; Zhou Y; Yuan L; Wang CM; Du CY; Zhou XY; Zheng BQ; Cao X; Sun MH; Fu H; Shi YQ
    Cancer; 2011 Dec; 117(23):5304-13. PubMed ID: 21567388
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer.
    Cao L; Yu Y; Bilke S; Walker RL; Mayeenuddin LH; Azorsa DO; Yang F; Pineda M; Helman LJ; Meltzer PS
    Cancer Res; 2010 Aug; 70(16):6497-508. PubMed ID: 20663909
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.
    Bravo IM; Correnti M; Escalona L; Perrone M; Brito A; Tovar V; Rivera H
    Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E33-9. PubMed ID: 16388291
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma.
    Khnykin D; Troen G; Berner JM; Delabie J
    J Pathol; 2006 Feb; 208(3):431-8. PubMed ID: 16353171
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cellular signaling by fibroblast growth factor receptors.
    Eswarakumar VP; Lax I; Schlessinger J
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):139-49. PubMed ID: 15863030
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
    Ho CL; Sheu LF; Li CY
    Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Paediatric oral surgical pathology service in an African population group: a 10 year review.
    Lawoyin JO
    Odontostomatol Trop; 2000 Mar; 23(89):27-30. PubMed ID: 11372144
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Localization of two tyrosine kinase receptor genes with respect to the 5q35 chromosomal breakpoint of Ki-1 lymphoma cell lines.
    Pébusque MJ; Lafage-Pochitaloff M; Galland F; Simonetti J; Armstrong E; Rimokh R; Birnbaum D
    Genes Chromosomes Cancer; 1993 Oct; 8(2):119-26. PubMed ID: 7504515
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [A comparative study of VEPA and ACOMEP-BD regimen for the patients with non-Hodgkin's lymphoma].
    Kanamori H; Tanabe J; Okamoto R; Tamura T; Fujita H; Murata T; Hashimoto Y; Harano H; Matsuzaki M; Motomura S
    Rinsho Ketsueki; 1993 Jun; 34(6):697-704. PubMed ID: 8366571
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Localization of the fibroblast growth factor receptor-4 gene to chromosome region 5q33-qter.
    Armstrong E; Partanen J; Cannizzaro L; Huebner K; Alitalo K
    Genes Chromosomes Cancer; 1992 Jan; 4(1):94-8. PubMed ID: 1377018
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pulmonary complications of chemotherapy regimens containing bleomycin.
    Balikian JP; Jochelson MS; Bauer KA; Skarkin AT; Garnick MB; Canellos GP; Smith EH
    AJR Am J Roentgenol; 1982 Sep; 139(3):455-61. PubMed ID: 6180618
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.